FOS and metabolic dysfunction-associated steatohepatitis: However, the consistent inhibition of SREBP2 and the activation of fos proto-oncogene (FOS) and PGC1α in mouse NASH models mimicked human steatosis but were absent in the setting of human fibrosis (Table 3) [102,213,214].